Therapeutic activity of inhibition of the soluble epoxide hydrolase in a mouse model of scrapie

Life Sciences

Volumn 92, Issue 23, 2013, Pages 1145-1150

  Poli, Giorgio ^a   Corda, Erica ^a   Martino, Piera Anna ^a   Dall'Ara, Paola ^a   Bareggi, Silvio R ^b   Bondiolotti, Giampietro ^b   Iulini, Barbara ^c   Mazza, Maria ^c   Casalone, Cristina ^c   Hwang, Sung Hee ^d   Hammock, Bruce D ^d   Inceoglu, Bora ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c DIF   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

EET; Epoxy fatty acid; Inflammation; Inhibitor; Neuroinflammation; Prion; Soluble epoxide hydrolase

Indexed keywords

CYTOCHROME P450; EPOXIDE HYDROLASE; HYDROLASE INHIBITOR; SOLUBLE EPOXIDE HYDROLASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME DEGRADATION; ENZYME INHIBITION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LETHALITY; MOUSE; NONHUMAN; PRION; SCRAPIE; SURVIVAL; WESTERN BLOTTING;

ANIMALS; BENZOATES; BLOTTING, WESTERN; BRAIN; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPOXIDE HYDROLASES; FEMALE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENTRICULAR; MICE; PRIONS; SCRAPIE; UREA;

ANIMALIA; MUS;

EID: 84878530520     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.04.014     Document Type: Article

References (36)

1. E. Abdu, D.A. Bruun, D. Yang, J. Yang, B. Inceoglu, and B.D. Hammock Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures J Neurochem 117 2011 632 642
2. S.R. Bareggi, D. Braida, C. Pollera, G. Bondiolotti, E. Formentin, and M. Puricelli Effects of clioquinol on memory impairment and the neurochemical modifications induced by scrapie infection in golden hamsters Brain Res 1280 2009 195 200
3. F. Checler, and B. Vincent Alzheimer's and prion diseases: distinct pathologies, common proteolytic denominators Trends Neurosci 25 2002 616 620
4. D.W. Dickson Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies Neurobiol Aging 18 1997 S21 S26
5. A.M. Dorrance, N. Rupp, D.M. Pollock, J.W. Newman, B.D. Hammock, and J.D. Imig An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats J Cardiovasc Pharmacol 46 2005 842 848
6. H. Fraser, and A.G. Dickinson The sequential development of the brain lesion of scrapie in three strains of mice J Comp Pathol 78 1968 301 311
7. J.S. Griffith Self-replication and scrapie Nature 215 1967 1043 1044
8. M. Heikenwalder, C. Julius, and A. Aguzzi Prions and peripheral nerves: a deadly rendezvous J Neurosci Res 85 2007 2714 2725
9. S.H. Hwang, C. Morisseau, Z. Do, and B.D. Hammock Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors Bioorg Med Chem Lett 16 2006 5773 5777
10. S.H. Hwang, H.J. Tsai, J.Y. Liu, C. Morisseau, and B.D. Hammock Orally bioavailable potent soluble epoxide hydrolase inhibitors J Med Chem 50 2007 3825 3840
11. J.D. Imig, and B.D. Hammock Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Nat Rev Drug Discov 8 2009 794 805
12. B. Inceoglu, S.L. Jinks, K.R. Schmelzer, T. Waite, I.H. Kim, and B.D. Hammock Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain Life Sci 79 2006 2311 2319
13. B. Inceoglu, S.L. Jinks, A. Ulu, C.M. Hegedus, K. Georgi, and K.R. Schmelzer Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways Proc Natl Acad Sci U S A 105 2008 18901 18906
14. B. Inceoglu, K.R. Schmelzer, C. Morisseau, S.L. Jinks, and B.D. Hammock Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs) Prostaglandins Other Lipid Mediat 82 2007 42 49
15. B. Inceoglu, K. Wagner, N.H. Schebb, C. Morisseau, S.L. Jinks, and A. Ulu Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP Proc Natl Acad Sci U S A 108 2011 5093 5097
16. B. Inceoglu, K.M. Wagner, J. Yang, A. Bettaieb, N.H. Schebb, and S.H. Hwang Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetes Proc Natl Acad Sci U S A 109 2012 11390 11395
17. R.H. Ingraham, R.D. Gless, and H.Y. Lo Soluble epoxide hydrolase inhibitors and their potential for treatment of multiple pathologic conditions Curr Med Chem 18 2011 587 603
18. C. Julius, M. Heikenwalder, P. Schwarz, A. Marcel, M. Karin, and M. Prinz Prion propagation in mice lacking central nervous system NF-kappaB signalling J Gen Virol 89 2008 1545 1550
19. J.Y. Liu, J. Yang, B. Inceoglu, H. Qiu, A. Ulu, and S.H. Hwang Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model Biochem Pharmacol 79 2010 880 887
20. G. Magri, M. Clerici, P. Dall'Ara, M. Biasin, M. Caramelli, and C. Casalone Decrease in pathology and progression of scrapie after immunisation with synthetic prion protein peptides in hamsters Vaccine 23 2005 2862 2868
21. H.C. Meeker, X. Ye, and R.I. Carp The mouse model for scrapie: inoculation, clinical scoring, and histopathological techniques Methods Mol Biol 299 2005 309 323
22. G. Poli, E. Corda, B. Lucchini, M. Puricelli, P.A. Martino, and P. Dall'ara Therapeutic effect of CHF5074, a new gamma-secretase modulator, in a mouse model of scrapie Prion 2012 6
23. G. Poli, P.A. Martino, S. Villa, G. Carcassola, M.L. Giannino, and P. Dall'Ara Evaluation of anti-prion activity of congo red and its derivatives in experimentally infected hamsters Arzneimittelforschung 54 2004 406 415
24. S. Prusiner Novel proteinaceous infectious particles cause scrapie Science 216 1982 136 144
25. S.B. Prusiner Prions Proc Natl Acad Sci 95 1998 13363 13383
26. L. Ronga, B. Tizzano, P. Palladino, R. Ragone, E. Urso, and M. Maffia The prion protein: structural features and related toxic peptides Chem Biol Drug Des 68 2006 139 147
27. M. Salmona, R. Capobianco, L. Colombo, A. De Luigi, G. Rossi, and M. Mangieri Role of plasminogen in propagation of scrapie J Virol 79 2005 11225 11230
28. P. Sarkar, J. Narayanan, and D.R. Harder Differential effect of amyloid beta on the cytochrome P450 epoxygenase activity in rat brain Neuroscience 194 2011 241 249
29. K.R. Schmelzer, B. Inceoglu, L. Kubala, I.H. Kim, S.L. Jinks, and J.P. Eiserich Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors Proc Natl Acad Sci U S A 103 2006 13646 13651
30. H.C. Shen, and B.D. Hammock Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications J Med Chem 55 2012 1789 1808
31. A.A. Spector Arachidonic acid cytochrome P450 epoxygenase pathway J Lipid Res 50 2009 S52 S56 [Suppl.]
32. P. Spilman, P. Lessard, M. Sattavat, C. Bush, T. Tousseyn, and E.J. Huang A gamma-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains Proc Natl Acad Sci U S A 105 2008 10595 10600
33. P. Sura, R. Sura, A.E. Enayetallah, and D.F. Grant Distribution and expression of soluble epoxide hydrolase in human brain J Histochem Cytochem 56 2008 551 559
34. A.M. Thackray, M.A. Klein, A. Aguzzi, and R. Bujdoso Chronic subclinical prion disease induced by low-dose inoculum J Virol 76 2002 2510 2517
35. H.J. Tsai, S.H. Hwang, C. Morisseau, J. Yang, P.D. Jones, and T. Kasagami Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs Eur J Pharm Sci 40 2010 222 238
36. K. Wagner, B. Inceoglu, and B.D. Hammock Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception Prostaglandins Other Lipid Mediat 96 2011 76 83